beta

ACHV

Achieve Life Sciences Inc.

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

	03-13-2019 after market close	03-13-2019 after market close	03-13-2019 after market close	03-13-2019 after market close	03-13-2019 after market close	03-13-2019 after market close	03-13-2019 after market close	03-13-2019 after market close	03-13-2019 after market close	03-13-2019 after market close	03-13-2019 after market close	03-13-2019 after market close	03-13-2019 after market close	03-13-2019 after market close	03-13-2019 after market close	03-13-2019 after market close	03-13-2019 after market close	03-13-2019 after market close	03-13-2019 after market close	03-13-2019 after market close	03-13-2019 after market close	11-07-2018 after market close	08-08-2018 after market close	05-09-2018	03-01-2018	11-09-2017	07-31-2017
Actual EPS	-0.55	-0.55	-0.55	-0.55	-0.55	-0.55	-0.55	-0.55	-0.55	-0.55	-0.55	-0.55	-0.55	-0.55	-0.55	-0.55	-0.55	-0.55	-0.55	-0.55	-0.55	-0.71	-1.82	-0.24	-0.32	-0.9	-0.1
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Achieve Life Sciences Inc is a specialty pharmaceutical company. The company is developing cytisine as a smoking cessation aid. The cytisine is a plant-based alkaloid with a high binding affinity to the nicotinic acetylcholine receptor.

Market Cap: 22.6 Million

Primary Exchange: NASDAQ Capital Market

Website: http://www.achievelifesciences.com

Shares Outstanding: 11.9 Million

Float: 9.35 Million

Dividend: 0.0 (0.0%)

Beta: 2.271952

Sector: Healthcare

Industry: Biotechnology

Short Interest (Jan 12, 2018): 189 Thousand

Ethical Flags

Longest drawdown: 1324 trading days

From: 2014-03-10 To: 2019-06-12

Lowest Point:

Healthcare tops midday movers

via: SeekingAlpha at 2019-06-11 08:41:05:000

Gainers: Jaguar Health (NASDAQ: JAGX ) +60% . ContraVir Pharmaceuticals (NASDAQ: CTRV ) +40% . TORM (NASDAQ: TRMD ) +20% . Rekor Systems, Inc. (REKR) +17% . Enzo Biochem, Inc. (NYSE: ENZ ) +17% . Oxbridge Re Holdings (NASDAQ: OXBR ) +16% . Tenax Therapeutics (NASDAQ: TENX ) +1… read more...

Healthcare tops midday movers

via: SeekingAlpha at 2019-06-11 08:41:05:000

Healthcare tops midday movers

via: SeekingAlpha at 2019-06-11 08:41:05:000

HDS, SYMC and BYND among premarket losers

via: SeekingAlpha at 2019-06-11 05:16:59:000

CymaBay Therapeutics (NASDAQ: CBAY ) -45% on disappointing data on NASH candidate seladelpar. More news on: CymaBay Therapeutics, Inc., Achieve Life Sciences, Inc., Beyond Meat, Inc., Stocks on the move, Read more … read more...

HDS, SYMC and BYND among premarket losers

via: SeekingAlpha at 2019-06-11 05:16:59:000

HDS, SYMC and BYND among premarket losers

via: SeekingAlpha at 2019-06-11 05:16:59:000

Achieve Life Sciences up 16% premarket on positive cytisinicline data

via: SeekingAlpha at 2019-06-11 04:13:28:000

Achieve Life Sciences (NASDAQ: ACHV ) is up 16% premarket on robust volume in response to results from the Phase 2 ORCA-1 dose-selection study of cytisinicline for smoking cessation. More news on: Achieve Life Sciences, Inc., Healthcare stocks news, Stocks on the move, Cons… read more...

Achieve Life Sciences up 16% premarket on positive cytisinicline data

via: SeekingAlpha at 2019-06-11 04:13:28:000

Achieve Life Sciences up 16% premarket on positive cytisinicline data

via: SeekingAlpha at 2019-06-11 04:13:28:000

Achieve Life Sciences Announces Statistically Significant Improvement in Quit Rates for Simplified Cytisinicline Dosing Schedule in Phase 2b ORCA-1 Dose-Selection Trial

via: PR Newswire at 2019-06-11 03:00:00:000

3.0 mg, 3 times daily selected as dose for future clinical development SEATTLE and VANCOUVER, British Columbia , June 11, 2019 /PRNewswire/ --Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company focused on nicotine addiction, today announced posi… read more...

Achieve Life Sciences Announces Statistically Significant Improvement in Quit Rates for Simplified Cytisinicline Dosing Schedule in Phase 2b ORCA-1 Dose-Selection Trial

via: PR Newswire at 2019-06-11 03:00:00:000

Achieve Life Sciences Announces Statistically Significant Improvement in Quit Rates for Simplified Cytisinicline Dosing Schedule in Phase 2b ORCA-1 Dose-Selection Trial

via: PR Newswire at 2019-06-11 03:00:00:000

Achieve Receives $4.2 Million from Exercise of Warrants

via: PR Newswire at 2019-06-03 12:05:00:000

SEATTLE and VANCOUVER, British Columbia , June 3, 2019 /PRNewswire/ --Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation, today announced that it enter… read more...

Achieve Receives $4.2 Million from Exercise of Warrants

via: PR Newswire at 2019-06-03 12:05:00:000

Achieve Receives $4.2 Million from Exercise of Warrants

via: PR Newswire at 2019-06-03 12:05:00:000

Achieve Life Sciences nabs new patent in U.S.; shares up 7% premarket

via: SeekingAlpha at 2019-05-30 03:30:49:000

The USPTO has granted Achieve Life Sciences (NASDAQ: ACHV ), a patent (No. 10,300,050) on succinate salt of cytisinicline and use thereof. More news on: Achieve Life Sciences, Inc., Healthcare stocks news, Stocks on the move, Read more … read more...

Achieve Life Sciences nabs new patent in U.S.; shares up 7% premarket

via: SeekingAlpha at 2019-05-30 03:30:49:000

Achieve Life Sciences nabs new patent in U.S.; shares up 7% premarket

via: SeekingAlpha at 2019-05-30 03:30:49:000

Achieve Announces Patent Granted in the U.S. for Novel Formulation of Cytisinicline

via: PR Newswire at 2019-05-30 01:30:00:000

SEATTLE and VANCOUVER, British Columbia , May 30, 2019 /PRNewswire/ --Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation, today announced that the Unit… read more...

Achieve Announces Patent Granted in the U.S. for Novel Formulation of Cytisinicline

via: PR Newswire at 2019-05-30 01:30:00:000

Achieve Announces Patent Granted in the U.S. for Novel Formulation of Cytisinicline

via: PR Newswire at 2019-05-30 01:30:00:000

Achieve Life Sciences, Inc. (ACHV) CEO Rick Stewart on Q1 2019 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-05-15 17:27:07:000

Achieve Life Sciences, Inc. (ACHV) Q1 2019 Results Conference Call May 15, 2019 04:30 PM ET Company Participants Jaime Xinos - EVP, Commercial Rick Stewart - CEO Dr. Cindy Jacobs - Chief Medical Officer Conference Call Participants Michael Higgins - Ladenburg Thalmann Joh… read more...

Achieve Life Sciences, Inc. (ACHV) CEO Rick Stewart on Q1 2019 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-05-15 17:27:07:000

Achieve Life Sciences, Inc. (ACHV) CEO Rick Stewart on Q1 2019 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-05-15 17:27:07:000

Data readout on Achieve's cytisinicline expected next month; shares down 3% after hours

via: SeekingAlpha at 2019-05-15 12:47:20:000

In its Q1 report , Achieve Life Sciences (NASDAQ: ACHV ) announces that topline results from the Phase 2b ORCA-1 trial evaluating smoking cessation med cytisinicline should be available by the end of next month. The last study visit by the last enrollee has taken place. More news o… read more...

Achieve Life Sciences misses by $0.25

via: SeekingAlpha at 2019-05-15 12:08:55:000

Achieve Life Sciences (NASDAQ: ACHV ): Q1 GAAP EPS of -$0.88 misses by $0.25 . More news on: Achieve Life Sciences, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Achieve Reports Financial Results for First Quarter 2019 and Provides Cytisinicline Clinical Development Update

via: PR Newswire at 2019-05-15 12:05:00:000

SEATTLE and VANCOUVER, British Columbia , May 15, 2019 /PRNewswire/ --Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation, today provided an update on… read more...

Achieve Life Sciences to Announce First Quarter 2019 Financial Results and Host Conference Call and Webcast on May 15, 2019

via: PR Newswire at 2019-05-07 01:30:00:000

SEATTLE andVANCOUVER, British Columbia , May 7, 2019 /PRNewswire/ --Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation, today announced that it w… read more...

Achieve Life Sciences to Announce First Quarter 2019 Financial Results and Host Conference Call and Webcast on May 15, 2019

via: PR Newswire at 2019-05-07 01:30:00:000

Achieve Life Sciences to Announce First Quarter 2019 Financial Results and Host Conference Call and Webcast on May 15, 2019

via: PR Newswire at 2019-05-07 01:30:00:000

Achieve Life Sciences Announces Last Subject, Last Visit Completed in Phase 2b ORCA-1 Trial of Cytisinicline for Smoking Cessation

via: PR Newswire at 2019-04-24 01:30:00:000

SEATTLE and VANCOUVER, British Columbia , April 24, 2019 /PRNewswire/ --Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation, today announced that the la… read more...

Achieve Life Sciences Announces Last Subject, Last Visit Completed in Phase 2b ORCA-1 Trial of Cytisinicline for Smoking Cessation

via: PR Newswire at 2019-04-24 01:30:00:000

Achieve Life Sciences Announces Last Subject, Last Visit Completed in Phase 2b ORCA-1 Trial of Cytisinicline for Smoking Cessation

via: PR Newswire at 2019-04-24 01:30:00:000

Achieve Life Sciences to Present at HC Wainwright Global Life Sciences Conference on April 8, 2019

via: PR Newswire at 2019-04-03 01:30:00:000

SEATTLE, Wash. and VANCOUVER, British Columbia , April 3, 2019 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation, today announced tha… read more...

Achieve Life Sciences to Present at HC Wainwright Global Life Sciences Conference on April 8, 2019

via: PR Newswire at 2019-04-03 01:30:00:000

Achieve Life Sciences to Present at HC Wainwright Global Life Sciences Conference on April 8, 2019

via: PR Newswire at 2019-04-03 01:30:00:000

MNKD, TTM among premarket gainers

via: SeekingAlpha at 2019-04-02 05:21:26:000

ADMA Biologics (NASDAQ: ADMA ) +46% as FDA approves ADMA Biologics' ASCENIV. More news on: ADMA Biologics, Inc., Sangamo Therapeutics, Inc., Riot Blockchain, Inc., Stocks on the move, Read more … read more...

Achieve Life Sciences +13% on DSMC review of phase 2b ORCA-1 trial

via: SeekingAlpha at 2019-04-02 03:18:23:000

Data Safety Monitoring Committee (DSMC) has completed second and final safety review of Achieve Life Sciences' (NASDAQ: ACHV ) ORCA-1 trial, evaluating the effectiveness of cytisinicline for smoking cessation and potentially other addiction indications. More news on: Achieve Life Science… read more...

Achieve Life Sciences Announces Successful Completion of the Second and Final DSMC Review of Phase 2b ORCA-1 Trial of Cytisinicline for Smoking Cessation

via: PR Newswire at 2019-04-02 01:30:00:000

SEATTLE and VANCOUVER, British Columbia , April 2, 2019 /PRNewswire/ --Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation, today announced that the Dat… read more...

Achieve Life Sciences to Present at Oppenheimer's 29th Annual Healthcare Conference on March 20, 2019

via: PR Newswire at 2019-03-18 01:30:00:000

SEATTLE and VANCOUVER, British Columbia , March 18, 2019 /PRNewswire/ --Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation, today announced that Rick … read more...

Achieve Life Sciences to Present at Oppenheimer's 29th Annual Healthcare Conference on March 20, 2019

via: PR Newswire at 2019-03-18 01:30:00:000

Achieve Life Sciences to Present at Oppenheimer's 29th Annual Healthcare Conference on March 20, 2019

via: PR Newswire at 2019-03-18 01:30:00:000

Midday Gainers / Losers

via: SeekingAlpha at 2019-03-15 08:54:44:000

Gainers: Soleno Therapeutics (NASDAQ: SLNO ) +210% . Achieve Life Sciences (NASDAQ: ACHV ) +33% . Catasys (NASDAQ: CATS ) +26% . Prana Biotechnology (NASDAQ: PRAN ) +24% . Avid Technology (NASDAQ: AVID ) +23% . Magenta Therapeutics (NASDAQ: MGTA ) +22% . Leap Therapeutics (NASD… read more...

Midday Gainers / Losers

via: SeekingAlpha at 2019-03-15 08:54:44:000

Midday Gainers / Losers

via: SeekingAlpha at 2019-03-15 08:54:44:000

AVGO, BDSI and NVLN among premarket gainers

via: SeekingAlpha at 2019-03-15 05:22:33:000

Achieve Life Sciences (NASDAQ: ACHV ) +77% on advancement of cytisinicline. More news on: Achieve Life Sciences, Inc., Soleno Therapeutics, Inc., MDC Partners Inc., Stocks on the move, Read more … read more...

AVGO, BDSI and NVLN among premarket gainers

via: SeekingAlpha at 2019-03-15 05:22:33:000

AVGO, BDSI and NVLN among premarket gainers

via: SeekingAlpha at 2019-03-15 05:22:33:000

Achieve Life Sciences up 83% on advancement of cytisinicline

via: SeekingAlpha at 2019-03-15 04:20:14:000

Achieve Life Sciences (NASDAQ: ACHV ) is up 83% premarket on robust volume following its update on smoking cessation med cytisinicline. More news on: Achieve Life Sciences, Inc., Healthcare stocks news, Stocks on the move, Read more … read more...

Achieve Life Sciences up 83% on advancement of cytisinicline

via: SeekingAlpha at 2019-03-15 04:20:14:000

Achieve Life Sciences up 83% on advancement of cytisinicline

via: SeekingAlpha at 2019-03-15 04:20:14:000

Achieve Life Sciences, Inc. (ACHV) CEO Richard Stewart on Q4 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-03-14 17:53:05:000

Achieve Life Sciences, Inc. (ACHV) Q4 2018 Results Earnings Conference Call March 14, 2019, 04:30 PM ET Company Participants Jaime Xinos - EVP, Commercial Richard Stewart - Chairman and CEO John Bencich - EVP, CFO and Operating Officer Cindy Jacobs - EVP and Chief Medical Offic… read more...

Achieve Life Sciences, Inc. (ACHV) CEO Richard Stewart on Q4 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-03-14 17:53:05:000

Achieve Life Sciences, Inc. (ACHV) CEO Richard Stewart on Q4 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-03-14 17:53:05:000

Achieve Life Sciences beats by $0.09

via: SeekingAlpha at 2019-03-14 12:08:47:000

Achieve Life Sciences (NASDAQ: ACHV ): Q4 GAAP EPS of -$0.55 beats by $0.09. More news on: Achieve Life Sciences, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Achieve Reports Financial Results for Year-End 2018 and Provides Cytisinicline Clinical Development Update

via: PR Newswire at 2019-03-14 12:05:00:000

SEATTLE and VANCOUVER, British Columbia , March 14, 2019 /PRNewswire/ --Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation, today provided an update on… read more...

Achieve Life Sciences to Announce Fourth Quarter and Year-End 2018 Financial Results and Host Conference Call and Webcast on March 14, 2019

via: PR Newswire at 2019-03-05 00:30:00:000

SEATTLE and VANCOUVER, British Columbia , March 5, 2019 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation, today announced that it will repo… read more...

Achieve Life Sciences to Announce Fourth Quarter and Year-End 2018 Financial Results and Host Conference Call and Webcast on March 14, 2019

via: PR Newswire at 2019-03-05 00:30:00:000

Achieve Life Sciences to Announce Fourth Quarter and Year-End 2018 Financial Results and Host Conference Call and Webcast on March 14, 2019

via: PR Newswire at 2019-03-05 00:30:00:000

Midday Gainers / Losers

via: SeekingAlpha at 2019-02-25 12:46:37:000

Gainers: China Internet Nationwide Financial Services (NASDAQ: CIFS ) +137% . Spark Therapeutics (NASDAQ: ONCE ) +120% . Clementia Pharmaceuticals (NASDAQ: CMTA ) +74% . uniQure N.V. (NASDAQ: QURE ) +30% . Titan Pharmaceuticals (NASDAQ: TTNP ) +27% . CRISPR Therapeutics AG (NASD… read more...

Midday Gainers / Losers

via: SeekingAlpha at 2019-02-25 12:46:37:000

Midday Gainers / Losers

via: SeekingAlpha at 2019-02-25 12:46:37:000

MDR and SKYS among premarket losers

via: SeekingAlpha at 2019-02-25 09:10:26:000

Achieve Life Sciences (NASDAQ: ACHV ) -11% . More news on: Achieve Life Sciences, Inc., Riot Blockchain, Inc., McDermott International, Inc., Stocks on the move, Read more … read more...

MDR and SKYS among premarket losers

via: SeekingAlpha at 2019-02-25 09:10:26:000

Achieve Life Sciences (NASDAQ: ACHV ) -11% . More news on: Achieve Life Sciences, Inc., Riot Blockchain, Inc., McDermott International, Inc., Stocks on the move, Read more … read more...

MDR and SKYS among premarket losers

via: SeekingAlpha at 2019-02-25 09:10:26:000

Achieve Life Sciences (NASDAQ: ACHV ) -11% . More news on: Achieve Life Sciences, Inc., Riot Blockchain, Inc., McDermott International, Inc., Stocks on the move, Read more … read more...

KHC, Z, ROKU, IQ and TTD among notable midday movers

via: SeekingAlpha at 2019-02-22 13:02:47:000

Gainers: Achieve Life Sciences (NASDAQ: ACHV ) +78% . The Trade Desk (NASDAQ: TTD ) +31% . Wayfair (NYSE: W ) +29% . DMC Global (NASDAQ: BOOM ) +29% . Voyager Therapeutics (NASDAQ: VYGR ) +24% . Roku (NASDAQ: ROKU ) +23% . Universal Display (NASDAQ: OLED ) +23% . Zillow Group, Inc…. read more...

KHC, Z, ROKU, IQ and TTD among notable midday movers

via: SeekingAlpha at 2019-02-22 13:02:47:000

KHC, Z, ROKU, IQ and TTD among notable midday movers

via: SeekingAlpha at 2019-02-22 13:02:47:000

Z, ROKU, W among premarket gainers

via: SeekingAlpha at 2019-02-22 09:16:49:000

Achieve Life Sciences (NASDAQ: ACHV ) +66% on positive cytisinicline data . More news on: Achieve Life Sciences, Inc., Extraction Oil & Gas, Voyager Therapeutics, Stocks on the move, Read more … read more...

Z, ROKU, W among premarket gainers

via: SeekingAlpha at 2019-02-22 09:16:49:000

Z, ROKU, W among premarket gainers

via: SeekingAlpha at 2019-02-22 09:16:49:000

Achieve Life Sciences up 57% premarket on positive cytisinicline data

via: SeekingAlpha at 2019-02-22 08:40:23:000

Thinly traded nano cap Achieve Life Sciences (NASDAQ: ACHV ) is up 57% premarket on robust volume in reaction to final data from a Phase 1/2 clinical trial evaluating smoking cessation med cytisinicline. The data are being presented today at the Society for Research on Nicoti… read more...

Achieve Life Sciences up 57% premarket on positive cytisinicline data

via: SeekingAlpha at 2019-02-22 08:40:23:000

Achieve Life Sciences up 57% premarket on positive cytisinicline data

via: SeekingAlpha at 2019-02-22 08:40:23:000

Achieve Announces Final Data from Cytisinicline Phase I/II Multi-Dose, Pharmacokinetic and Pharmacodynamics (PK/PD) Clinical Study to be Presented at Society for Research on Nicotine & Tobacco Annual Meeting

via: PR Newswire at 2019-02-22 05:30:00:000

SEATTLE and VANCOUVER, British Columbia , Feb. 22, 2019 /PRNewswire/ --Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation, today announced final data f… read more...

Achieve Announces Final Data from Cytisinicline Phase I/II Multi-Dose, Pharmacokinetic and Pharmacodynamics (PK/PD) Clinical Study to be Presented at Society for Research on Nicotine & Tobacco Annual Meeting

via: PR Newswire at 2019-02-22 05:30:00:000

Achieve Announces Final Data from Cytisinicline Phase I/II Multi-Dose, Pharmacokinetic and Pharmacodynamics (PK/PD) Clinical Study to be Presented at Society for Research on Nicotine & Tobacco Annual Meeting

via: PR Newswire at 2019-02-22 05:30:00:000

Achieve completes enrollment in mid-stage study of smoking cessation candidate cytisinicline

via: SeekingAlpha at 2019-02-20 11:37:04:000

Achieve Life Sciences ( ACHV -1.5% ) has completed the enrollment of 254 subjects in a Phase 2b clinical trial, ORCA-1 , evaluating cytisinicline, plus behavioral support, for smoking cessation. More news on: Achieve Life Sciences, Inc., Healthcare stocks news, Read more … read more...

Achieve completes enrollment in mid-stage study of smoking cessation candidate cytisinicline

via: SeekingAlpha at 2019-02-20 11:37:04:000

Achieve Life Sciences Announces Completion of Enrollment in 254-Subject Phase 2b Trial of Cytisinicline for Smoking Cessation

via: PR Newswire at 2019-02-20 05:30:00:000

SEATTLE and VANCOUVER, British Columbia , Feb. 20, 2019 /PRNewswire/ --Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation, today announced the completi… read more...

Achieve Life Sciences Announces Completion of Enrollment in 254-Subject Phase 2b Trial of Cytisinicline for Smoking Cessation

via: PR Newswire at 2019-02-20 05:30:00:000

SSYS, ARRY among premarket gainers

via: SeekingAlpha at 2019-01-15 09:16:52:000

Kitov Pharma (NASDAQ: KTOV ) +60% on new findings from its ongoing collaboration with researchers from the Hebrew University ofJerusalem revealingNT219s high affinity and selective binding to its target proteins. More news on: Kitov Pharmaceuticals Holdings… read more...

SSYS, ARRY among premarket gainers

via: SeekingAlpha at 2019-01-15 09:16:52:000

SSYS, ARRY among premarket gainers

via: SeekingAlpha at 2019-01-15 09:16:52:000

Achieve Announces Update on Cytisinicline Clinical Development Program

via: PR Newswire at 2018-12-18 05:30:00:000

SEATTLE and VANCOUVER, British Columbia , Dec. 18, 2018 /PRNewswire/ --Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation, today provided a clinical de… read more...

Achieve Announces Update on Cytisinicline Clinical Development Program

via: PR Newswire at 2018-12-18 05:30:00:000

Achieve Announces Update on Cytisinicline Clinical Development Program

via: PR Newswire at 2018-12-18 05:30:00:000

Achieve Life Sciences, Inc. (ACHV) CEO Richard Stewart on Q3 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-11-07 22:49:31:000

Achieve Life Sciences, Inc. (ACHV) Q3 2018 Earnings Conference Call November 07, 2018, 04:30 PM ET Executives Jaime Welch - EVP, Commercial Richard Stewart - Chairman and CEO John Bencich - EVP, CFO and Operating Officer Cindy Jacobs - EVP and Chief Medical Officer Analysts … read more...

Achieve Life Sciences, Inc. (ACHV) CEO Richard Stewart on Q3 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-11-07 22:49:31:000

Achieve Life Sciences, Inc. (ACHV) CEO Richard Stewart on Q3 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-11-07 22:49:31:000

Achieve Life Sciences reports Q3 results

via: SeekingAlpha at 2018-11-07 16:22:27:000

Achieve Life Sciences (NASDAQ: ACHV ): Q3 GAAP EPS of -$0.71. More news on: Achieve Life Sciences, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Achieve Reports Financial Results for Third Quarter 2018 and Provides Cytisinicline (Cytisine) Clinical Development Update

via: PR Newswire at 2018-11-07 16:05:00:000

SEATTLE and VANCOUVER, British Columbia , Nov. 7, 2018 /PRNewswire/ --Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation, today provided an update on t… read more...

Achieve Life Sciences to Announce Third Quarter 2018 Financial Results and Host Conference Call and Webcast on November 7, 2018

via: PR Newswire at 2018-10-31 05:30:00:000

SEATTLE, Wash. and VANCOUVER, British Columbia , Oct. 31, 2018 /PRNewswire/ --Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline (cytisine) for smoking cessation, today anno… read more...

Achieve Life Sciences to Announce Third Quarter 2018 Financial Results and Host Conference Call and Webcast on November 7, 2018

via: PR Newswire at 2018-10-31 05:30:00:000

Achieve Life Sciences to Announce Third Quarter 2018 Financial Results and Host Conference Call and Webcast on November 7, 2018

via: PR Newswire at 2018-10-31 05:30:00:000

Strong earnings lead stocks higher premarket

via: SeekingAlpha at 2018-10-30 09:16:31:000

Electro Scientific (NASDAQ: ESIO ) +87% on Q2 result . More news on: Electro Scientific Industries, Inc., Achieve Life Sciences, Inc., Differential Brands Group Inc., Stocks on the move, , Top stock market news, Read more … read more...

Achieve Life Sciences launches mid-stage study of cytisinicline for smoking cessation; shares up 28% premarket

via: SeekingAlpha at 2018-10-30 08:21:18:000

Nano cap Achieve Life Sciences (NASDAQ: ACHV ) is up 28% premarket on above-average volume in response to its launch of a Phase 2 clinical trial, ORCA-1 , evaluating cytisinicline (cytisine) for smoking cessation. More news on: Achieve Life Sciences, Inc., Healthcare stocks … read more...

Achieve Life Sciences Announces Initiation of Phase 2b ORCA-1 Trial Evaluating Cytisinicline (cytisine) for Smoking Cessation

via: PR Newswire at 2018-10-30 05:30:00:000

SEATTLE and VANCOUVER, British Columbia , Oct. 30, 2018 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation, today announced initiation… read more...

Midday Gainers / Losers (10/01/2018)

via: SeekingAlpha at 2018-10-01 12:40:08:000

Gainers: OGEN +51% . LEVB +37% . NBEV +39% . ARCW +30% . NTGN +27% . IGC +25% . IFMK +24% . ACST +21% . ATLC +21% . ALT +21% . More news on: Oragenics, Inc., Level Brands, Inc., New Age Beverages Corporation, Stocks on the move, , Read more … read more...

Midday Gainers / Losers (10/01/2018)

via: SeekingAlpha at 2018-10-01 12:40:08:000

Midday Gainers / Losers (10/01/2018)

via: SeekingAlpha at 2018-10-01 12:40:08:000

Achieve Announces Pricing of $5.6 Million Registered Direct Offering

via: PR Newswire at 2018-10-01 09:05:00:000

SEATTLEand VANCOUVER, British Columbia , Oct. 1, 2018 /PRNewswire/ --Achieve Life Sciences,Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today announced that it ha… read more...

Achieve Announces Pricing of $5.6 Million Registered Direct Offering

via: PR Newswire at 2018-10-01 09:05:00:000

Achieve Announces Pricing of $5.6 Million Registered Direct Offering

via: PR Newswire at 2018-10-01 09:05:00:000

Midday Gainers / Losers (09/27/2018)

via: SeekingAlpha at 2018-09-27 12:40:42:000

Gainers: ACHV +58% . RXII +36% . IGC +26% . GBR +25% . HAIR +20% . YGYI +18% . NTGN +17% . LQDA +16% . ARAY +17% . CCJ +16% . More news on: Achieve Life Sciences, Inc., RXI Pharmaceuticals Corporation, India Globalization Capital, Inc, Stocks on the mo… read more...

Midday Gainers / Losers (09/27/2018)

via: SeekingAlpha at 2018-09-27 12:40:42:000

Midday Gainers / Losers (09/27/2018)

via: SeekingAlpha at 2018-09-27 12:40:42:000

Premarket Gainers as of 9:05 am (09/27/2018)

via: SeekingAlpha at 2018-09-27 09:11:59:000

ACHV +35% on performance of new cytisine formulation. More news on: Achieve Life Sciences, Inc., Cameco Corporation, India Globalization Capital, Inc, Stocks on the move, Top stock market news, , Read more … read more...

Premarket Gainers as of 9:05 am (09/27/2018)

via: SeekingAlpha at 2018-09-27 09:11:59:000

Premarket Gainers as of 9:05 am (09/27/2018)

via: SeekingAlpha at 2018-09-27 09:11:59:000

Achieve Life Sciences up 38% premarket on performance of new cytisine formulation

via: SeekingAlpha at 2018-09-27 07:55:50:000

Nano cap Achieve Life Sciences (NASDAQ: ACHV ) is up 38% premarket on increased volume in response to its announcement that a new formulation of smoking cessation candidate cytisine demonstrated bioequivalence in healthy volunteer smokers with or without food. The results were … read more...

Achieve Life Sciences up 38% premarket on performance of new cytisine formulation

via: SeekingAlpha at 2018-09-27 07:55:50:000

Achieve Life Sciences up 38% premarket on performance of new cytisine formulation

via: SeekingAlpha at 2018-09-27 07:55:50:000

Achieve Announces Results of Clinical Study Demonstrating Similar Bioavailability for a New Cytisine Formulation in Fed and Fasted Subjects

via: PR Newswire at 2018-09-27 05:30:00:000

SEATTLEand VANCOUVER, British Columbia , Sept. 27, 2018 /PRNewswire/ -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today announced results of a clini… read more...

Achieve Announces Results of Clinical Study Demonstrating Similar Bioavailability for a New Cytisine Formulation in Fed and Fasted Subjects

via: PR Newswire at 2018-09-27 05:30:00:000

Achieve Announces Results of Clinical Study Demonstrating Similar Bioavailability for a New Cytisine Formulation in Fed and Fasted Subjects

via: PR Newswire at 2018-09-27 05:30:00:000

Achieve to Present at the Ladenburg Thalmann 2018 Healthcare Conference on October 2, 2018

via: PR Newswire at 2018-09-26 05:30:00:000

SEATTLE and VANCOUVER, British Columbia , Sept. 26, 2018 /PRNewswire/ --Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today announced that Rick Stewa… read more...

Midday Gainers / Losers (09/24/2018)

via: SeekingAlpha at 2018-09-24 12:35:13:000

Gainers: AMRN +233% . SAEX +153% . GBR +41% . JONE +27% . IPCI +26% . XON +23% . CRC +17% . AGTC +16% . PEIX +15% . ACHV +15% . More news on: Amarin Corporation PLC, SAExploration Holdings, Inc., New Concept Energy, Inc., , Stocks on the move, Top stoc… read more...

Midday Gainers / Losers (09/24/2018)

via: SeekingAlpha at 2018-09-24 12:35:13:000

Achieve Life Sciences up 12% premarket on new cytisine data

via: SeekingAlpha at 2018-09-18 08:58:31:000

Nano cap Achieve Life Sciences (NASDAQ: ACHV ) is up 12% premarket on light volume on the heels of new data from an observational study in Russia for smoking cessation candidate cytisine. The results were just published in the International Journal of Drug Policy . More news… read more...

Achieve Life Sciences up 12% premarket on new cytisine data

via: SeekingAlpha at 2018-09-18 08:58:31:000

Achieve Life Sciences up 12% premarket on new cytisine data

via: SeekingAlpha at 2018-09-18 08:58:31:000

Achieve Announces Positive Cytisine Data Published in International Journal of Drug Policy

via: PR Newswire at 2018-09-18 05:30:00:000

SEATTLE, Wash. and VANCOUVER, British Columbia , Sept. 18, 2018 /PRNewswire/ --Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today announced the publi… read more...

Achieve Announces Positive Cytisine Data Published in International Journal of Drug Policy

via: PR Newswire at 2018-09-18 05:30:00:000

Achieve Announces Positive Cytisine Data Published in International Journal of Drug Policy

via: PR Newswire at 2018-09-18 05:30:00:000

Achieve Life Sciences Announces Cytisine Data Presented at the Society for Research on Nicotine and Tobacco Europe (SRNT-E) Annual Conference

via: PR Newswire at 2018-09-06 05:30:00:000

SEATTLE and VANCOUVER, British Columbia , Sept. 6, 2018 /PRNewswire/ --Achieve Life Sciences, Inc. (NASDAQ: ACHV), today announced that cytisine data will be presented at the Society for Research on Nicotine and Tobacco Europe (SRNT-E) Annual Conference , September 6-8 th in M… read more...

Achieve Life Sciences Announces Cytisine Data Presented at the Society for Research on Nicotine and Tobacco Europe (SRNT-E) Annual Conference

via: PR Newswire at 2018-09-06 05:30:00:000

Achieve Life Sciences Announces Cytisine Data Presented at the Society for Research on Nicotine and Tobacco Europe (SRNT-E) Annual Conference

via: PR Newswire at 2018-09-06 05:30:00:000

Achieve to Present at the H.C. Wainwright 20th Annual Global Investment Conference on September 6, 2018

via: PR Newswire at 2018-09-05 05:30:00:000

SEATTLE and VANCOUVER, British Columbia , Sept. 5, 2018 /PRNewswire/ -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today announced that John Bencich , C… read more...

Achieve Life Sciences, Inc. (ACHV) CEO Richard Stewart on Q2 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-08-08 18:52:07:000

Achieve Life Sciences, Inc. (ACHV) Q2 2018 Results Earnings Conference Call August 08, 2018, 04:30 PM ET Executives Jaime Welch - Executive Vice President, Commercial Richard Stewart - Chairman and Chief Executive Officer John Bencich - Executive VP, CFO and Operating Officer A… read more...

Achieve Life Sciences, Inc. (ACHV) CEO Richard Stewart on Q2 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-08-08 18:52:07:000

Achieve Life Sciences, Inc. (ACHV) CEO Richard Stewart on Q2 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-08-08 18:52:07:000

Achieve Life Sciences reports Q2 results

via: SeekingAlpha at 2018-08-08 16:12:09:000

Achieve Life Sciences (NASDAQ: ACHV ): Q2 EPS of -$1.82 More news on: Achieve Life Sciences, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Achieve Life Sciences reports Q2 results

via: SeekingAlpha at 2018-08-08 16:12:09:000

Achieve Life Sciences (NASDAQ: ACHV ): Q2 EPS of -$1.82 More news on: Achieve Life Sciences, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Achieve Life Sciences reports Q2 results

via: SeekingAlpha at 2018-08-08 16:12:09:000

Achieve Life Sciences (NASDAQ: ACHV ): Q2 EPS of -$1.82 More news on: Achieve Life Sciences, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Achieve Reports Financial Results for Second Quarter 2018 and Provides Cytisine Clinical Development Update

via: PR Newswire at 2018-08-08 16:05:00:000

SEATTLE and VANCOUVER, British Columbia , Aug. 8, 2018 /PRNewswire/ -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today provided an update on the cytisin… read more...

Achieve Reports Financial Results for Second Quarter 2018 and Provides Cytisine Clinical Development Update

via: PR Newswire at 2018-08-08 16:05:00:000

Achieve Reports Financial Results for Second Quarter 2018 and Provides Cytisine Clinical Development Update

via: PR Newswire at 2018-08-08 16:05:00:000

Achieve Life Sciences to Release Second Quarter 2018 Financial Results and Host Conference Call and Webcast on August 8, 2018

via: PR Newswire at 2018-08-02 05:30:00:000

SEATTLE and VANCOUVER, British Columbia , Aug. 2, 2018 /PRNewswire/ --Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today announced that it will repor… read more...

Achieve Life Sciences to Release Second Quarter 2018 Financial Results and Host Conference Call and Webcast on August 8, 2018

via: PR Newswire at 2018-08-02 05:30:00:000

Achieve Life Sciences to Release Second Quarter 2018 Financial Results and Host Conference Call and Webcast on August 8, 2018

via: PR Newswire at 2018-08-02 05:30:00:000

Your Daily Pharma Scoop: ResTORbio Progresses, Roche Closer To Review, AbbVie Falters

via: SeekingAlpha at 2018-07-13 04:16:50:000

Stocks in News: TORC, RHHBY ResTORbio's RTB101 shows treatment benefit in mid-stage study; shares up 9% Discussion : ResTORbio ( TORC ) announced positive results from a Phase 2a clinical trial of its lead drug RTB101 in elderly patients. The candidate was on trial testing its infecti… read more...

Your Daily Pharma Scoop: ResTORbio Progresses, Roche Closer To Review, AbbVie Falters

via: SeekingAlpha at 2018-07-13 04:16:50:000

Your Daily Pharma Scoop: ResTORbio Progresses, Roche Closer To Review, AbbVie Falters

via: SeekingAlpha at 2018-07-13 04:16:50:000

Your Daily Pharma Scoop: ResTORbio Progresses, Roche Closer To Review, AbbVie Falters

via: SeekingAlpha at 2018-07-13 04:16:50:000

Your Daily Pharma Scoop: ResTORbio Progresses, Roche Closer To Review, AbbVie Falters

via: SeekingAlpha at 2018-07-13 04:16:50:000

Midday Gainers / Losers (07/11/2018)

via: SeekingAlpha at 2018-07-11 12:42:53:000

Gainers: MDGS +79% . MYOS +42% . BIOC +28% . ACHV +24% . TKAT +18% . ACIU +15% . MYGN +15% . WMLP +14% . MTSL +14% . INTX +13% . More news on: Medigus Ltd, MYOS RENS Technology, Biocept, Inc., Stocks on the move, , Read more … read more...

Midday Gainers / Losers (07/11/2018)

via: SeekingAlpha at 2018-07-11 12:42:53:000

Premarket Gainers as of 9:05 am (07/11/2018)

via: SeekingAlpha at 2018-07-11 09:14:44:000

MTSL +53% . More news on: MER Telemanagement Solutions Ltd., Achieve Life Sciences, Inc., Asterias Biotherapeutics, Inc., Stocks on the move, Read more … read more...

Premarket Gainers as of 9:05 am (07/11/2018)

via: SeekingAlpha at 2018-07-11 09:14:44:000

MTSL +53% . More news on: MER Telemanagement Solutions Ltd., Achieve Life Sciences, Inc., Asterias Biotherapeutics, Inc., Stocks on the move, Read more … read more...

Achieve Life Sciences up 19% premarket on cytisine development plan

via: SeekingAlpha at 2018-07-11 06:54:48:000

Nano cap Achieve Life Sciences (NASDAQ: ACHV ) is up 19% premarket on light volume in response to its updated development plan for smoking cessation drug cytisine. More news on: Achieve Life Sciences, Inc., Healthcare stocks news, Stocks on the move, Read more … read more...

Achieve Life Sciences up 19% premarket on cytisine development plan

via: SeekingAlpha at 2018-07-11 06:54:48:000

Achieve Life Sciences Announces Advancement of Cytisine Development Program Following Meeting with the FDA

via: PR Newswire at 2018-07-11 05:30:00:000

SEATTLE and VANCOUVER, British Columbia , July 11, 2018 /PRNewswire/ --Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today announced an update on the … read more...

Achieve Life Sciences Announces Advancement of Cytisine Development Program Following Meeting with the FDA

via: PR Newswire at 2018-07-11 05:30:00:000

Your Daily Pharma Scoop: Glaukos And Achaogen Approvals, Puma Up On EU Prospects, FOLD Down

via: SeekingAlpha at 2018-06-28 08:00:00:000

Readers note: The Analysis Focus section is now only available to TPT subscribers . This follows the announcement from yesterday. Stocks in News: GKOS, AKAO Glaukos wins FDA approval for treatment managing glaucoma patients IOP Glaukos ( GKOS ) received FDA approval for it… read more...

Your Daily Pharma Scoop: Glaukos And Achaogen Approvals, Puma Up On EU Prospects, FOLD Down

via: SeekingAlpha at 2018-06-28 08:00:00:000

Your Daily Pharma Scoop: Glaukos And Achaogen Approvals, Puma Up On EU Prospects, FOLD Down

via: SeekingAlpha at 2018-06-28 08:00:00:000

Premarket Gainers as of 9:05 am (06/26/2018)

via: SeekingAlpha at 2018-06-26 09:18:33:000

LEE +46% on deal with Berkshire. More news on: Lee Enterprises, Incorporated, Achieve Life Sciences, Inc., Avinger, Stocks on the move, Read more … read more...

Premarket Gainers as of 9:05 am (06/26/2018)

via: SeekingAlpha at 2018-06-26 09:18:33:000

LEE +46% on deal with Berkshire. More news on: Lee Enterprises, Incorporated, Achieve Life Sciences, Inc., Avinger, Stocks on the move, Read more … read more...

Achieve Life Sciences +47% on results of smoking cessation aid studies

via: SeekingAlpha at 2018-06-26 08:36:03:000

Achieve Life Sciences (NASDAQ: ACHV ) +47.3% premarket after announcing positive results from a series of drug metabolism, drug-drug interaction and transporter studies with cytisine, its product candidate being evaluated as an aid to smoking cessation. More news on: Achieve Life Scien… read more...

Achieve Life Sciences +47% on results of smoking cessation aid studies

via: SeekingAlpha at 2018-06-26 08:36:03:000

Achieve Announces Positive Cytisine Data Demonstrating No Clinically Significant Drug-Drug Interaction

via: PR Newswire at 2018-06-26 05:30:00:000

SEATTLE and VANCOUVER, British Columbia , June 26, 2018 /PRNewswire/ --Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company, today announced positive results from a series of drug metabolism, drug-drug interaction and transporter studies with cytisin… read more...

Achieve Announces Positive Cytisine Data Demonstrating No Clinically Significant Drug-Drug Interaction

via: PR Newswire at 2018-06-26 05:30:00:000

Premarket Gainers as of 9:05 am (6/25/2018)

via: SeekingAlpha at 2018-06-25 09:23:50:000

XRM +101% on being acquired by Andritz AG. More news on: Xerium Technologies, Inc., Legacy Reserves LP Cum Red Perp Pfd Units Series B, Valeritas Holdings, Inc., Stocks on the move, Read more … read more...

Achieve Life Sciences, Inc. Announces Closing of a $13.8 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option

via: PR Newswire at 2018-06-19 16:01:00:000

SEATTLE and VANCOUVER, British Columbia , June 19, 2018 /PRNewswire/ -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today announced the closing of an unde… read more...

Achieve Life Sciences, Inc. Announces Closing of a $13.8 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option

via: PR Newswire at 2018-06-19 16:01:00:000

Achieve Life Sciences, Inc. Announces Closing of a $13.8 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option

via: PR Newswire at 2018-06-19 16:01:00:000

Midday Gainers / Losers (06/15/2018)

via: SeekingAlpha at 2018-06-15 12:36:26:000

Gainers: CLPS +34% . GOOS +27% . NDRA +24% . BAK +19% . TPIV +19% . VSTM +16% . CFRX +15% . NETE +14% . TCI +14% . NEWA +13% . More news on: CLPS, Inc, Canada Goose Holdings, Endra Life Sciences Inc, Stocks on the move, , Read more … read more...

Midday Gainers / Losers (06/15/2018)

via: SeekingAlpha at 2018-06-15 12:36:26:000

Midday Gainers / Losers (06/15/2018)

via: SeekingAlpha at 2018-06-15 12:36:26:000

Midday Gainers / Losers (06/15/2018)

via: SeekingAlpha at 2018-06-15 12:36:26:000

Premarket Losers as of 9:05 am (6/15/2018)

via: SeekingAlpha at 2018-06-15 09:14:23:000

ACHV -28% on continued sell off. More news on: Achieve Life Sciences, Inc., Affimed Therapeutics, Destination Maternity Corporation, Stocks on the move, , Read more … read more...

Premarket Losers as of 9:05 am (6/15/2018)

via: SeekingAlpha at 2018-06-15 09:14:23:000

ACHV -28% on continued sell off. More news on: Achieve Life Sciences, Inc., Affimed Therapeutics, Destination Maternity Corporation, Stocks on the move, , Read more … read more...

Premarket Losers as of 9:05 am (6/15/2018)

via: SeekingAlpha at 2018-06-15 09:14:23:000

ACHV -28% on continued sell off. More news on: Achieve Life Sciences, Inc., Affimed Therapeutics, Destination Maternity Corporation, Stocks on the move, , Read more … read more...

Premarket Losers as of 9:05 am (6/15/2018)

via: SeekingAlpha at 2018-06-15 09:14:23:000

ACHV -28% on continued sell off. More news on: Achieve Life Sciences, Inc., Affimed Therapeutics, Destination Maternity Corporation, Stocks on the move, , Read more … read more...

Achieve Life Sciences Announces Pricing of $12 Million Underwritten Public Offering

via: PR Newswire at 2018-06-15 08:30:00:000

SEATTLE and VANCOUVER, British Columbia , June 15, 2018 /PRNewswire/ --Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today announced the pricing of an… read more...

Achieve Life Sciences Announces Pricing of $12 Million Underwritten Public Offering

via: PR Newswire at 2018-06-15 08:30:00:000

Achieve Life Sciences Announces Pricing of $12 Million Underwritten Public Offering

via: PR Newswire at 2018-06-15 08:30:00:000

Achieve Life Sciences Announces Pricing of $12 Million Underwritten Public Offering

via: PR Newswire at 2018-06-15 08:30:00:000

Achieve Life Sciences continues selloff, down 13% premarket

via: SeekingAlpha at 2018-06-15 07:32:47:000

Thinly traded nano cap Achieve Life Sciences (NASDAQ: ACHV ) is down 13% premarket on light volume. Shares have sold off almost 65% since touching $14.60 on May 7. More news on: Achieve Life Sciences, Inc., Healthcare stocks news, Stocks on the move, Read more …. read more...

Achieve Life Sciences continues selloff, down 13% premarket

via: SeekingAlpha at 2018-06-15 07:32:47:000

Achieve Life Sciences continues selloff, down 13% premarket

via: SeekingAlpha at 2018-06-15 07:32:47:000

Achieve Life Sciences continues selloff, down 13% premarket

via: SeekingAlpha at 2018-06-15 07:32:47:000

Midday Gainers / Losers (06/14/2018)

via: SeekingAlpha at 2018-06-14 12:49:59:000

Gainers: AGMH +79% . FLKS +48% . ETSY +30% . DEST +27% . THST +26% . NITE +20% . DBX +18% . INSY +16% . CLPS +12% . LIVX +13% . More news on: AGM Group Holdings Inc., Flex Pharma, Etsy, Inc., Stocks on the move, , Read more … read more...

Achieve Announces Publication of Cytisine Data for Next-Generation Cytisine Molecules

via: PR Newswire at 2018-06-11 05:30:00:000

SEATTLE and VANCOUVER, British Columbia , June 11, 2018 /PRNewswire/ --Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today announced that cytisine dat… read more...

Achieve Announces Publication of Cytisine Data for Next-Generation Cytisine Molecules

via: PR Newswire at 2018-06-11 05:30:00:000

Achieve Announces Publication of Cytisine Data for Next-Generation Cytisine Molecules

via: PR Newswire at 2018-06-11 05:30:00:000

Midday Gainers / Losers (05/24/2018)

via: SeekingAlpha at 2018-05-24 12:50:06:000

Gainers: CHCI +132% . SBOT +34% . UVV +28% . HDSN +20% . CATO +20% . DEST +18% . EOLS +17% . AXTI +16% . VIVE +15% . ACHV +13% . More news on: Comstock Homebuilding Companies, Inc., Stellar Biotechnologies Inc., Universal Corporation, Stocks on the move, , … read more...

Midday Gainers / Losers (05/24/2018)

via: SeekingAlpha at 2018-05-24 12:50:06:000

Midday Gainers / Losers (05/24/2018)

via: SeekingAlpha at 2018-05-24 12:50:06:000

Midday Gainers / Losers (05/24/2018)

via: SeekingAlpha at 2018-05-24 12:50:06:000

Achieve Life Sciences, Inc. Announces Reverse Stock Split

via: PR Newswire at 2018-05-23 05:30:00:000

SEATTLE and VANCOUVER, British Columbia , May 23, 2018 /PRNewswire/ --Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today announced a reverse stock sp… read more...

Achieve Life Sciences, Inc. Announces Reverse Stock Split

via: PR Newswire at 2018-05-23 05:30:00:000

Achieve Life Sciences, Inc. Announces Reverse Stock Split

via: PR Newswire at 2018-05-23 05:30:00:000

Achieve Life Sciences, Inc. Announces Reverse Stock Split

via: PR Newswire at 2018-05-23 05:30:00:000

Midday Gainers / Losers (05/11/2018)

via: SeekingAlpha at 2018-05-11 12:41:01:000

Gainers: ANFI +83% . HEAR +48% . TTD +40% . ARCB +28% . WOW +28% . OMER +24% . MOSY +24% . BOXL +20% . BLNK +20% . EOLS +17% . More news on: Amira Nature Foods, Turtle Beach Corporation, The Trade Desk, Stocks on the move, , Read more … read more...

Midday Gainers / Losers (05/11/2018)

via: SeekingAlpha at 2018-05-11 12:41:01:000

Midday Gainers / Losers (05/11/2018)

via: SeekingAlpha at 2018-05-11 12:41:01:000

Achieve Life Sciences reports Q1 results

via: SeekingAlpha at 2018-05-09 16:54:28:000

Achieve Life Sciences (NASDAQ: ACHV ): Q1 EPS of -$0.24 Cash, cash equivalents, short-term investments and restricted cash of $4.4M Press Release More news on: Achieve Life Sciences, Inc., Earnings news and commentary, Healthcare stocks news, , read more...

Achieve Life Sciences reports Q1 results

via: SeekingAlpha at 2018-05-09 16:54:28:000

Achieve Life Sciences reports Q1 results

via: SeekingAlpha at 2018-05-09 16:54:28:000

Achieve Reports Financial Results for First Quarter 2018

via: PR Newswire at 2018-05-09 16:15:00:000

SEATTLE and VANCOUVER, British Columbia , May 9, 2018 /PRNewswire/ --Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today announced first quarter 20… read more...

Achieve Reports Financial Results for First Quarter 2018

via: PR Newswire at 2018-05-09 16:15:00:000

Achieve Reports Financial Results for First Quarter 2018

via: PR Newswire at 2018-05-09 16:15:00:000

Achieve Announces Patent Granted on Novel Formulation of Cytisine

via: PR Newswire at 2018-05-07 05:30:00:000

SEATTLE and VANCOUVER, British Columbia , May 7, 2018 /PRNewswire/ --Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today announced that the UK Intelle… read more...

Achieve Announces Patent Granted on Novel Formulation of Cytisine

via: PR Newswire at 2018-05-07 05:30:00:000

Achieve Announces Patent Granted on Novel Formulation of Cytisine

via: PR Newswire at 2018-05-07 05:30:00:000

Achieve Life Sciences Announces Cytisine Symposium at the 17th World Conference on Tobacco or Health

via: PR Newswire at 2018-03-06 05:30:00:000

BOTHELL, Wash. and VANCOUVER, British Columbia , March 6, 2018 /PRNewswire/ -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), today announced that the World Conference on Tobacco or Health (WCTOH) will be holding a symposium on cytisine research at this year's annual conference, March 7-9… read more...

Achieve Life Sciences Announces Cytisine Symposium at the 17th World Conference on Tobacco or Health

via: PR Newswire at 2018-03-06 05:30:00:000